Recent News for A - Agilent Technologies, Inc.

Date Title
Feb 22 Agilent’s pharmDx assay approved for use in non-small cell lung cancer
Feb 22 Agilent PD-L1 IHC 22C3 pharmDx Receives Expanded FDA Approval in Non-small Cell Lung Cancer (NSCLC)
Feb 19 Bill Ackman Slims Down Top Holdings in 4th Quarter
Feb 19 At US$128, Is It Time To Put Agilent Technologies, Inc. (NYSE:A) On Your Watch List?
Feb 18 Agilent Ranks No. 2 on Barron’s List of America’s Most Sustainable Companies
Feb 18 Agilent Announces Immunoassay Kit to Detect SARS-CoV-2 Antibodies
Feb 18 Agilent Technologies, Inc. 2021 Q1 - Results - Earnings Call Presentation
Feb 17 P/E Ratio Insights for Agilent Technologies
Feb 17 Agilent Announces Higher-Sensitivity XF Analysis Solution for Low Abundant Immune Cell Metabolic Analysis
Feb 17 Agilent raised to buy at BofA on growth outperformance
Feb 17 Agilent Technologies Inc (A) Q1 2021 Earnings Call Transcript
Feb 17 Agilent Technologies Inc. (A) CEO Mike McMullen on Q1 2021 Results - Earnings Call Transcript
Feb 16 Bill Ackman's Pershing Square slightly trims Lowe's, Starbucks, QSR stakes
Feb 16 Agilent is up after earnings beat and guidance raise
Feb 16 Recap: Agilent Technologies Q1 Earnings
Feb 16 Agilent Technologies shares up 2% on better-than-expected earnings, sales
Feb 16 Agilent Technologies EPS beats by $0.16, beats on revenue
Feb 16 Agilent Reports First-Quarter Fiscal Year 2021 Financial Results
Feb 15 Agilent Technologies FQ1 2021 Earnings Preview
Feb 14 Wall Street Breakfast: The Week Ahead
Feb 12 Is a Surprise Coming for Agilent (A) This Earnings Season?
Feb 10 Looking Into Agilent Technologies's Return On Capital Employed
Feb 9 Agilent Technologies (A) Earnings Expected to Grow: Should You Buy?
Feb 9 What Makes Agilent (A) a New Buy Stock
Feb 8 Agilent to Present at Upcoming Investor Events; Provides Webcast Details for Annual Shareholder Meeting
Back to the Main A Page...